Tradestie Institutional Equity Comparison Engine

ANL vs SVRA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SVRA Overall Edge

SVRA Captures Institutional Edge (3โ€“1 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Savara Inc. (SVRA) driven by superior Valuation, Growth & Margin, Options & Structure while ANL counters with relative strength in Momentum & Technical. Fundamentally, ANL trades at N/M Forward P/E with -123.5% operating margin (+178.1% YoY revenue) versus SVRA at 0.4x Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, ANL sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SVRA sits in BREAKDOWN (17th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner SVRA
ANL N/M vs SVRA 0.4x Fwd P/E
Growth & Margin Winner SVRA
Op Margin -123.5% vs 0.0% ยท YoY +178.1% vs +0.0%
Momentum & Technical Winner ANL
1Y +560.3% vs +3.9% ยท 52W Pos 56% vs 13%
Options & Structure Winner SVRA
UNCLASSIFIED (N/A IV) vs BREAKDOWN (17th %ile IV)
ANL US Equity
ANL
Institutional Equity
$9.97
-6.03% 1D
Market Cap $677.5M
1M Return -9.61%
1Y Return +560.26%
Forward P/E N/M
Unified AI Score
48.3 / 100 HOLD
Tech 48.0 Fund 52.0 Flow 50.0 Mom 50.0
SVRA NASDAQ
Savara Inc.
Pharmaceutical Preparations
$4.42
-4.63% 1D
Market Cap $1.1B
1M Return -0.56%
1Y Return +3.87%
Forward P/E 0.4x
Unified AI Score
57.7 / 100 HOLD
Tech 42.0 Fund 54.0 Flow 70.0 Mom 54.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ANL +560.26% SVRA +3.87% Spread: +556.39 pp (ANL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ANL TTM Op. Margin: -123.5% SVRA TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ANL vs SVRA. Trailing 12-month operating profitability (ANL -123.5% vs SVRA 0.0%) and valuation multiples (ANL N/M vs SVRA 0.4x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ANL (3) vs SVRA (7)
Institutional Metric ANL SVRA Criterion Row Winner
Market Capitalization Scale $677.5M $1.1B Larger Scale SVRA
Trailing P/E Ratio Valuation N/M 0.4x Lower Multiple SVRA
Forward P/E Ratio Valuation N/M 0.4x Lower Multiple SVRA
Revenue Growth (YoY) Growth +178.1% +0.0% Higher Growth ANL
Operating Margin (TTM) Profitability -123.5% 0.0% Higher Margin SVRA
Net Profit Margin Profitability -124.8% 0.0% Higher Margin SVRA
Return on Equity (ROE) Capital Efficiency -20.2% -151.0% Higher ROE ANL
52-Week Range Position Momentum 56% ($1โ€“$17) 13% ($4โ€“$7) Stronger Trend ANL
Beta / 30D Volatility Risk Regime 2.61ฮฒ ยท 79% Vol 1.48ฮฒ ยท 73% Vol Lower Realized Risk SVRA
Unified Institutional Score Composite Signal 48.3 / 100 (HOLD) 57.7 / 100 (HOLD) Higher Composite SVRA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ANL vs SVRA Buy Guide
ANL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ANL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SVRA BREAKDOWN
92d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 17th %ile
IV Regime Compressed (<25th %ile)
Live SVRA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ANL nor SVRA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.